The IDO pathway exerts an immunological role by controlling (inhibiting) inflammation, along with induction of the tolerogenic arm of adaptive immune responses in the tumor milieu. Upregulation of IDO depletes the essential amino acid tryptophan leading to activation of the stress-response kinase GCN2, which is a critical molecule involved in sensing amino acid withdrawal (25). The gene discussed is IDO1; the disease is neoplasm.